Drugs / FOLFOXIRI
last change Dec 2014 re-read 3 minutes ago

FOLFOXIRI

Developed for
malignant pancreatic neoplasm
Investigated by
Azienda Ospedaliero, Universitaria Pisana

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02351219 Dec 2012 → Dec 2014 malignant pancreatic neoplasm Azienda Ospedaliero, Universitaria Pisana Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as FOLFOXIRI ClinicalTrials.gov intervention name — accepted as the source's own label NCT02351219 ↗